These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9021179)

  • 1. Uptake and intracellular activity of trovafloxacin in human phagocytes and tissue-cultured epithelial cells.
    Pascual A; García I; Ballesta S; Perea EJ
    Antimicrob Agents Chemother; 1997 Feb; 41(2):274-7. PubMed ID: 9021179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake and intracellular activity of moxifloxacin in human neutrophils and tissue-cultured epithelial cells.
    Pascual A; García I; Ballesta S; Perea EJ
    Antimicrob Agents Chemother; 1999 Jan; 43(1):12-5. PubMed ID: 9869557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake and intracellular activity of sparfloxacin in human polymorphonuclear leukocytes and tissue culture cells.
    García I; Pascual A; Guzman MC; Perea EJ
    Antimicrob Agents Chemother; 1992 May; 36(5):1053-6. PubMed ID: 1324636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake and intracellular activity of ofloxacin isomers in human phagocytic and non-phagocytic cells.
    García I; Pascual A; Ballesta S; Perea EJ
    Int J Antimicrob Agents; 2000 Aug; 15(3):201-5. PubMed ID: 10926442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular penetration and activity of BAY Y 3118 in human polymorphonuclear leukocytes.
    García I; Pascual A; Perea EJ
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2426-9. PubMed ID: 7840582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular penetration and activity of gemifloxacin in human polymorphonuclear leukocytes.
    García I; Pascual A; Ballesta S; Joyanes P; Perea EJ
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3193-5. PubMed ID: 11036051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.
    Gootz TD; Zaniewski RP; Haskell SL; Kaczmarek FS; Maurice AE
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1845-55. PubMed ID: 10428901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of the effects of inoculum size on the antimicrobial action of trovafloxacin and ciprofloxacin against Staphylococcus aureus and Escherichia coli in an in vitro dynamic model.
    Firsov AA; Vostrov SN; Kononenko OV; Zinner SH; Portnoy YA
    Antimicrob Agents Chemother; 1999 Mar; 43(3):498-502. PubMed ID: 10049257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Entry of lomefloxacin and temafloxacin into human neutrophils, peritoneal macrophages, and tissue culture cells.
    Pascual A; Garcia I; Perea EJ
    Diagn Microbiol Infect Dis; 1992 Jul; 15(5):393-8. PubMed ID: 1322808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to trovafloxacin.
    Bonilla HF; Zarins LT; Bradley SF; Kauffman CA
    Diagn Microbiol Infect Dis; 1996 Sep; 26(1):17-21. PubMed ID: 8950524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of paclitaxel alone or in combination on the intracellular penetration and activity of quinolones in human neutrophils.
    García I; Pascual A; Salvador J; Conejo MC; Perea EJ
    J Antimicrob Chemother; 1996 Nov; 38(5):859-63. PubMed ID: 8961056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative penetration of lomefloxacin and other quinolones into human phagocytes.
    Perea EJ; García I; Pascual A
    Am J Med; 1992 Apr; 92(4A):48S-51S. PubMed ID: 1316071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates.
    Felmingham D; Robbins MJ; Ingley K; Mathias I; Bhogal H; Leakey A; Ridgway GL; Grüneberg RN
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():43-9. PubMed ID: 9222069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa in vitro corneal isolate sensitivity to ofloxacin, ciprofloxacin, and trovafloxacin: a comparative study.
    Song A; McCulley TJ; Lam BL; Feuer WJ; Miller D; Alfonso EC
    Am J Ophthalmol; 2001 Jun; 131(6):795-6. PubMed ID: 11384579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antistaphylococcal and antistreptococcal killing kinetics of ciprofloxacin, ofloxacin, sparfloxacin, and trovafloxacin.
    Prenna M; Montanari MP; Mingoia M; Biavasco F; Ripa S; Varaldo PE
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):816-9. PubMed ID: 9923533
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
    Gilbert DN; Kohlhepp SJ; Slama KA; Grunkemeier G; Lewis G; Dworkin RJ; Slaughter SE; Leggett JE
    Antimicrob Agents Chemother; 2001 Mar; 45(3):883-92. PubMed ID: 11181375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of recent gram-positive isolates to ciprofloxacin, levofloxacin, and trovafloxacin.
    Isenberg HD; Alperstein P; France K
    Diagn Microbiol Infect Dis; 1998 Oct; 32(2):115-8. PubMed ID: 9823535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin.
    Bauernfeind A
    J Antimicrob Chemother; 1997 Nov; 40(5):639-51. PubMed ID: 9421311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia.
    Edelstein PH; Edelstein MA; Ren J; Polzer R; Gladue RP
    Antimicrob Agents Chemother; 1996 Feb; 40(2):314-19. PubMed ID: 8834872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus with ciprofloxacin and trovafloxacin.
    Evans ME; Titlow WB
    Antimicrob Agents Chemother; 1998 Mar; 42(3):727. PubMed ID: 9517965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.